PRELIOS: REQUEST TO ADD ITEMS TO THE AGENDA OF THE SHAREHOLDERS’ MEETING

Price sensitive

Milan, 19 April 2016 – Prelios S.p.A. (“Prelios” or the “Company”) announces that is has received from Negentropy Capital Partners LLP, which declares to act for and on behalf of the investment fund Negentropy Sicaf-Sif / Negentropy Special Situation Fund, Luxembourg, (“Negentropy”) which holds no. 38,173,500 ordinary shares of the Company, equal to 3.31% of the voting share capital, a request to add items to the agenda of the Ordinary Shareholders’ Meeting called for 19 May 2016, pursuant to Art. 126-bis of Legislative Decree no. 58 of 24 February 1998 and subsequent amendments and integrations (the “Consolidated Law on Finance“).

Request has been made to add the following item to the agenda: “Appointment of up to a maximum of 3 new directors subject to the redetermination of the number of members of the Board of Directors from the current 11 (eleven) up to 13 (thirteen) members. Contingent resolutions.” Considering the requested addition, Negentropy has also asked that the related items be discussed at the Meeting immediately after the first item on the agenda, “Financial statements as at and for the year ended 31 December 2015. Contingent resolutions”, so as assimilate and replace the discussion and deliberation of what is currently the second point on the agenda, “The appointment of a director and / or reduction in the number of directors. Contingent resolutions.”

Negentropy - while pointing out the fact that it is party to a shareholder agreement entered into on 26 February 2016 and subsequently amended on 7 March 2016 concerning Prelios shares and holding, in total, no. 267,590,087 ordinary Prelios shares, equal to 23.206% of the voting share capital - proposes, in particular to: (i) redetermine the number of members of the Board of Directors by increasing it from the current 11 (eleven) up to 13 (thirteen) members; (ii) appoint up to 3 (three) new directors on the understanding that the new directors shall remain in office until the end of the current term of the Board of Directors and, therefore, until the Shareholders’ Meeting that will be called to approve the financial statements as at and for the year ended 31 December 2017.

The Company’s Board of Directors is expected to meet in the coming days to address the resolutions.